MedLumics key facts
- Manufacturer of a radio frequency cardiac ablation system intended to offer treatment of supraventricular tachycardias.
- It has raised $67.9M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include MedTech Innovator, INNVIERTE SICC, Kurma Partners, Andera Partners, Caixa Capital Risc — 18 tracked in total.
- Status: Privately Held (backing).
Who backs MedLumics
18+- ·The complete investor list: 18 names
- ·Watch MedLumics: the Monday email on marks, rounds and moves
MedLumics funding rounds
No funding rounds for MedLumics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
MedLumics investors
18 investors are on record for MedLumics, including MedTech Innovator, INNVIERTE SICC, Kurma Partners and Andera Partners.
About MedLumics
Manufacturer of a radio frequency cardiac ablation system intended to offer treatment of supraventricular tachycardias. The company's system provides real-time, direct visual, confirmation of catheter contact, and contact stability during tissue ablation, enabling doctors to access reduced recurrence rates and procedure technical complexity while increasing procedural safety.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2009
- Employees
- 27
- Website
- medlumics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
MedLumics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.